Change Partners
ABOUT CHANGE PARTNERS
Change Partners is a CMVM-registered SCR and one of Portugal's oldest venture firms, operating from Porto since 1989. It invests at Series A in Portuguese companies across life sciences, enterprise software, and agri-food. Change Partners has made 11 investments and recorded one exit. Its portfolio includes GuestCentric, a hospitality software company, and Exogenus Therapeutics, a biotech developing regenerative treatments, along with Zypho, which was acquired. With more than three decades of activity, Change Partners is among the longest-established venture investors in the country and brings a Porto base to a market where much venture activity is concentrated in Lisbon. Its focus on enterprise applications, health and life sciences, and agri-food gives the firm a defined thesis backing Portuguese founders at the Series A stage, supporting companies as they move from early product validation toward commercial scale in specialized technical and scientific sectors.
INVESTMENT THESIS
Series A for Portuguese companies in life sciences, enterprise applications, and agri-food.
INVESTMENT DETAILS
FREQUENTLY ASKED QUESTIONS
What stage does Change Partners invest at?
Change Partners invests at Series A stage.
What sectors does Change Partners invest in?
Change Partners focuses on Life Sciences, Enterprise Software, AgriFood.
Where is Change Partners based?
Change Partners is a VC (SCR) based in Porto, Portugal, founded in 1989.
What companies has Change Partners invested in?
Change Partners's portfolio includes GuestCentric, Exogenus Therapeutics, Zypho.
Can I invest in Change Partners's funds as an external investor?
Change Partners raises its funds from external investors (LPs). No open subscription window is publicly announced right now — prospective LPs are typically onboarded when the next fund is raised.
How do I contact or pitch Change Partners?
You can reach Change Partners via their website (changepartners.pt). You can also run your startup through Portugal VC's AI matcher to get a ranked shortlist of the investors that fit.